ChiCTR2600116774 版本V1.0 版本创建时间2026/01/14 17:30:03 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600116774 

最近更新日期:

Date of Last Refreshed on:

2026-01-14 17:29:41 

注册时间:

Date of Registration:

2026-01-14 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

基于NCPM模型的结直肠癌患者围术期营养管理方案的构建和实证研究

Public title:

Construction and Empirical Research on Perioperative Nutritional Management Plan for Colorectal Cancer Patients Based on the NCPM Model

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于循证及NCPM模型的结直肠癌患者围术期全程营养管理方案的构建及实证研究

Scientific title:

Construction and Empirical Research on a Comprehensive Perioperative Nutritional Management Program for Colorectal Cancer Patients Based on Evidence-Based and NCPM Models

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

谭诗泳 

研究负责人:

郝燕萍 

Applicant:

Tan Shiyong 

Study leader:

Hao Yanping 

申请注册联系人电话:

Applicant telephone:

+86 178 7567 2327

研究负责人电话:

Study leader's
telephone:

+86 185 6504 9350

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

tansy_1218@163.com

研究负责人电子邮件:

Study leader's E-mail:

2050203236@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广州市越秀区东风西路195号

研究负责人通讯地址:

广州市越秀区东风西路195号

Applicant address:

No. 195, Dongfeng West Road, Yuexiu District, Guangzhou City

Study leader's address:

No. 195, Dongfeng West Road, Yuexiu District, Guangzhou City

申请注册联系人邮政编码:

Applicant postcode:

510180

研究负责人邮政编码:

Study leader's postcode:

510180

申请人所在单位:

广州医科大学

Applicant's institution:

Guangzhou Medical University

研究负责人所在单位:

广州医科大学

Affiliation of the Leader:

Guangzhou Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

202409014

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广州医科大学医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Guangzhou Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-10-11 00:00:00

伦理委员会联系人:

郝燕萍

Contact Name of the ethic committee:

Hao Yanping

伦理委员会联系地址:

广州市越秀区东风西路195号

Contact Address of the ethic committee:

No. 195, Dongfeng West Road, Yuexiu District, Guangzhou City

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 185 6504 9350

伦理委员会联系人邮箱:

Contact email of the ethic committee:

haoyp2024@sina.com

研究实施负责(组长)单位:

广州医科大学

Primary sponsor:

Guangzhou Medical University

研究实施负责(组长)单位地址:

广州市越秀区东风西路195号

Primary sponsor's address:

No. 195, Dongfeng West Road, Yuexiu District, Guangzhou City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州市

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州医科大学护理学院

具体地址:

广州市越秀区东风西路195号

Institution
hospital:

Guangzhou Medical University

Address:

No. 195, Dongfeng West Road, Yuexiu District, Guangzhou City

经费或物资来源:

广州医科大学

Source(s) of funding:

Guangzhou Medical University

研究疾病:

结直肠癌  

Target disease:

Colorectal cancer

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

本研究基于NCPM模型,旨在构建一套集营养评估、营养诊断、营养干预、营养监测与评价等为一体的科学、合理的结直肠癌患者围术期全程营养管理方案,以改善结直肠癌患者的营养状况,提高手术耐受性、术后康复效果及患者生活质量。提升医护、患者及其家属对围术期全程营养的重视程度及认知水平,加强患者及其家属的营养管理的能力及依从性。同时把该综合方案应用于实际的临床研究,评估基于循证及NCPM模型的结直肠癌患者围术期全程营养管理方案对围术期结直肠癌患者的临床效果,为后续临床实践和推广应用提供参考。  

Objectives of Study:

Based on the NCPM model, this study aims to construct a scientific and reasonable perioperative nutrition management program for patients with colorectal cancer that integrates nutritional assessment, nutritional diagnosis, nutritional intervention, nutritional monitoring and evaluation, etc., in order to improve the nutritional status of patients with colorectal cancer, and improve the tolerance of surgery, postoperative rehabilitation effect and quality of life of patients. Improve the attention and cognition level of medical care, patients and their families on perioperative nutrition, and strengthen the ability and compliance of patients and their families in nutrition management. At the same time, the comprehensive program was applied to actual clinical studies to evaluate the clinical effect of the perioperative whole-course nutrition management program for colorectal cancer patients based on evidence-based and NCPM model, so as to provide reference for subsequent clinical practice and application.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.经病理学及内镜检查确诊为结直肠癌, 择期行结直肠癌根治术;2.患者术前无其他恶性肿瘤病史;3.年龄≥18岁;4.患者知情同意并自愿签署知情同意书。

Inclusion criteria

1.Colorectal cancer was diagnosed by pathology and endoscopy, and radical resection of colorectal cancer was performed at an selected time. 2. The patient had no history of other malignant tumors before surgery; 3.Age >=18 years old; 4.The patient gives informed consent and signs the informed consent voluntarily.

排除标准:

1.存在严重心、肝、肺、肾等重要器官功能障碍,内分泌代谢或免疫系统疾病,严重感染及水、电解质平衡紊乱者;2.重度营养不良患者,血清白蛋白< 21 g/L;3.拟接受造口手术者;4.意识障碍等各种原因无法配合治疗者。

Exclusion criteria:

1.There are serious heart, liver, lung, kidney and other important organ dysfunction, endocrine metabolism or immune system diseases, serious infections and water and electrolyte balance disorders; 2. In patients with severe malnutrition, serum albumin < 21 g/L; 3. Patients who intend to receive stomy surgery; 4.Patients who cannot cooperate with treatment for various reasons such as consciousness disorders.

研究实施时间:

Study execute time:

From 2024-12-01 00:00:00 To 2026-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-12-05 00:00:00 To 2025-09-30 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

39

Group:

Experimental group

Sample size:

干预措施:

基于NCPM模型的结直肠癌患者围术期营养管理方案

干预措施代码:

Intervention:

Perioperative nutrition management scheme for colorectal cancer patients based on evidence-based and NCPM model

Intervention code:

组别:

对照组

样本量:

39

Group:

Control group

Sample size:

干预措施:

常规营养管理

干预措施代码:

Intervention:

Conventional nutritional management

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

广州市 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州医科大学护理学院 

单位级别:

大学 

Institution
hospital:

Guangzhou Medical University

Level of the institution:

University

国家:

中国

省(直辖市):

广东省 

市(区县):

广州市 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广州医科大学附属肿瘤医院 

单位级别:

三甲 

Institution
hospital:

The Affiliated Cancer Hospital of Guangzhou Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

广州市第一人民医院 

单位级别:

三甲 

Institution
hospital:

Guangzhou First People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

血清白蛋白

指标类型:

主要指标

Outcome:

Serum albumin

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

人体质量指数

指标类型:

次要指标

Outcome:

Body Mass Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

总蛋白

指标类型:

次要指标

Outcome:

Total protein

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血红蛋白

指标类型:

次要指标

Outcome:

Hemoglobin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

白细胞

指标类型:

次要指标

Outcome:

Leukocyte

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

淋巴细胞

指标类型:

次要指标

Outcome:

Lymphocyte

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后首次排气时间

指标类型:

次要指标

Outcome:

The First postoperative exhaust time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后首次排便时间

指标类型:

次要指标

Outcome:

Time of first postoperative defecation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后住院时间

指标类型:

次要指标

Outcome:

Postoperative hospital stay

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

住院费用

指标类型:

次要指标

Outcome:

Hospitalization expenses

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

并发症发生情况

指标类型:

次要指标

Outcome:

Occurrence of complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后30天再入院率

指标类型:

次要指标

Outcome:

Postoperative readmission

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

None

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束后6个月,经研究者同意后可邮箱获取;

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Six months after the study ends, it can be obtained via email with the researcher's consent.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表采集记录,电子系统管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Collection and record of medical records, electronic system management

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-01-14 17:29:41